The team from National Chiao-Tung University and National Dong-Hwa University found that ND-paclitaxel significantly reduced the size of tumours when the material was delivered to human lung carcinoma cells in xenograft SCID mice. However, ND alone did not alter the tumorigenesis of the lung cancer cells.

A full description of the study can be found in the journal Nanotechnology.